Alcoholic Fatty Liver: New Insights for the Healthcare Professional: 2011 Edition: ScholarlyPaper
ScholarlyEditions, Jan 9, 2012 - Medical - 20 pages
Alcoholic Fatty Liver: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Alcoholic Fatty Liver in a compact format.
The editors have built Alcoholic Fatty Liver: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Alcoholic Fatty Liver in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Alcoholic Fatty Liver: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility.
What people are saying - Write a review
The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease
Treatment of nonalcoholic fatty liver disease by Qianggan Capsule
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with nonalcoholic fatty liver disease
The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with dietinduced nonalcoholic fatty liver dise...
Genetic polymorphisms in nonalcoholic fatty liver disease Clues to pathogenesis and disease progression
Serum inflammatory markers in overweight children and adolescents with nonalcoholic fatty liver disease
The role of cytokines in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease the hepatic consequence of obesity and the metabolic syndrome
Environmental and genetic determinants of fatty liver in humans
Inhibition of acylcoenzyme Acholesterol acyltransferase 2 ACAT2 prevents dietary cholesterolassociated steatosis by enhancing hepatic triglyceride ...
Association between serum uric acid and nonalcoholic fatty liver disease in Korean adults